Bondwell Technologies

Bondwell Technologies is a biotechnology company founded in 2017 by scientists from Texas A&M University and headquartered in College Station, Texas. The company specializes in a proprietary protein-based biomaterial platform that utilizes the functional capabilities of proteins as molecular tools. This technology is engineered to possess specific structural, mechanical, and functional properties for diverse applications, including films, fibers, and high-resolution membranes. By embedding active biomolecules, Bondwell creates bioactive materials designed to operate with high affinity and specificity across various scientific and industrial fields.

The company focuses on applying its biomaterial platform to address challenges in sectors such as bioprocessing, drug manufacturing, energy, and medicine. Supported by funding from sources including the National Science Foundation's SBIR program, Bondwell has worked on developing high-efficiency, cost-effective purification technologies for therapeutic antibody manufacturing. By targeting the inefficiencies inherent in traditional resin-based manufacturing processes, the company aims to provide scalable alternatives that enhance performance in complex production environments.